BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mochizuki T, Arrigoni E, Marcus JN, Clark EL, Yamamoto M, Honer M, Borroni E, Lowell BB, Elmquist JK, Scammell TE. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A 2011;108:4471-6. [PMID: 21368172 DOI: 10.1073/pnas.1012456108] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Michael NJ, Zigman JM, Williams KW, Elmquist JK. Electrophysiological Properties of Genetically Identified Histaminergic Neurons. Neuroscience 2020;444:183-95. [PMID: 32599122 DOI: 10.1016/j.neuroscience.2020.06.031] [Reference Citation Analysis]
2 Peever J, Fuller PM. Neuroscience: A Distributed Neural Network Controls REM Sleep. Curr Biol 2016;26:R34-5. [PMID: 26766231 DOI: 10.1016/j.cub.2015.11.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
3 Dugovic C, Shelton JE, Yun S, Bonaventure P, Shireman BT, Lovenberg TW. Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism. Front Neurosci 2014;8:28. [PMID: 24592208 DOI: 10.3389/fnins.2014.00028] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
4 Jacobson LH, Chen S, Mir S, Hoyer D. Orexin OX2 Receptor Antagonists as Sleep Aids. In: Lawrence AJ, de Lecea L, editors. Behavioral Neuroscience of Orexin/Hypocretin. Cham: Springer International Publishing; 2017. pp. 105-36. [DOI: 10.1007/7854_2016_47] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
5 Leonard CS, Ishibashi M. Orexin Receptor Functions in the Ascending Arousal System. In: Sakurai T, Pandi-perumal S, Monti JM, editors. Orexin and Sleep. Cham: Springer International Publishing; 2015. pp. 67-80. [DOI: 10.1007/978-3-319-23078-8_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Schöne C, Apergis-Schoute J, Sakurai T, Adamantidis A, Burdakov D. Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons. Cell Rep 2014;7:697-704. [PMID: 24767990 DOI: 10.1016/j.celrep.2014.03.055] [Cited by in Crossref: 103] [Cited by in F6Publishing: 98] [Article Influence: 12.9] [Reference Citation Analysis]
7 Tisdale RK, Yamanaka A, Kilduff TS. Animal models of narcolepsy and the hypocretin/orexin system: Past, present, and future. Sleep 2021;44:zsaa278. [PMID: 33313880 DOI: 10.1093/sleep/zsaa278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Arrigoni E, Chee MJS, Fuller PM. To eat or to sleep: That is a lateral hypothalamic question. Neuropharmacology 2019;154:34-49. [PMID: 30503993 DOI: 10.1016/j.neuropharm.2018.11.017] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
9 Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): The ultimate translational neuropeptides. J Intern Med 2022. [PMID: 35043499 DOI: 10.1111/joim.13406] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Burgess CR, Scammell TE. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci 2012;32:12305-11. [PMID: 22956821 DOI: 10.1523/JNEUROSCI.2630-12.2012] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
11 Szakacs Z, Dauvilliers Y, Mikhaylov V, Poverennova I, Krylov S, Jankovic S, Sonka K, Lehert P, Lecomte I, Lecomte JM, Schwartz JC; HARMONY-CTP study group. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2017;16:200-7. [PMID: 28129985 DOI: 10.1016/S1474-4422(16)30333-7] [Cited by in Crossref: 95] [Cited by in F6Publishing: 29] [Article Influence: 19.0] [Reference Citation Analysis]
12 Arrigoni E, Fuller PM. The Circuit, Cellular, and Synaptic Bases of Sleep-Wake Regulation. Handbook of Sleep Research. Elsevier; 2019. pp. 65-88. [DOI: 10.1016/b978-0-12-813743-7.00005-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Strambi LF. A need for new treatments in narcolepsy. The Lancet Neurology 2013;12:1039-40. [DOI: 10.1016/s1474-4422(13)70178-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
15 Li J, Hu Z, de Lecea L. The hypocretins/orexins: integrators of multiple physiological functions. Br J Pharmacol 2014;171:332-50. [PMID: 24102345 DOI: 10.1111/bph.12415] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 19.1] [Reference Citation Analysis]
16 Shiromani PJ, Peever JH. New Neuroscience Tools That Are Identifying the Sleep-Wake Circuit. Sleep 2017;40. [PMID: 28329204 DOI: 10.1093/sleep/zsx032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
17 Jaggard JB, Stahl BA, Lloyd E, Prober DA, Duboue ER, Keene AC. Hypocretin underlies the evolution of sleep loss in the Mexican cavefish. Elife 2018;7:e32637. [PMID: 29405117 DOI: 10.7554/eLife.32637] [Cited by in Crossref: 52] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
18 Christopher JA. Small-molecule antagonists of the orexin receptors. Pharm Pat Anal 2014;3:625-38. [PMID: 25489915 DOI: 10.4155/ppa.14.46] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
19 Messina A, De Fusco C, Monda V, Esposito M, Moscatelli F, Valenzano A, Carotenuto M, Viggiano E, Chieffi S, De Luca V, Cibelli G, Monda M, Messina G. Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis. Front Neural Circuits 2016;10:66. [PMID: 27610076 DOI: 10.3389/fncir.2016.00066] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
20 Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding C, Lecomte J, Schwartz J. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. The Lancet Neurology 2013;12:1068-75. [DOI: 10.1016/s1474-4422(13)70225-4] [Cited by in Crossref: 207] [Cited by in F6Publishing: 62] [Article Influence: 23.0] [Reference Citation Analysis]
21 Rihel J, Schier AF. Sites of action of sleep and wake drugs: insights from model organisms. Curr Opin Neurobiol 2013;23:831-40. [PMID: 23706898 DOI: 10.1016/j.conb.2013.04.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
22 Hasegawa E, Yanagisawa M, Sakurai T, Mieda M. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. J Clin Invest 2014;124:604-16. [PMID: 24382351 DOI: 10.1172/JCI71017] [Cited by in Crossref: 96] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
23 Vringer M, Kornum BR. Emerging therapeutic targets for narcolepsy. Expert Opin Ther Targets 2021;:1-14. [PMID: 34402358 DOI: 10.1080/14728222.2021.1969361] [Reference Citation Analysis]
24 Scammell TE, Jackson AC, Franks NP, Wisden W, Dauvilliers Y. Histamine: neural circuits and new medications. Sleep 2019;42. [PMID: 30239935 DOI: 10.1093/sleep/zsy183] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
25 Eban-Rothschild A, de Lecea L. Neuronal substrates for initiation, maintenance, and structural organization of sleep/wake states. F1000Res 2017;6:212. [PMID: 28357049 DOI: 10.12688/f1000research.9677.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
26 Rozov SV, Zant JC, Karlstedt K, Porkka-Heiskanen T, Panula P. Periodic properties of the histaminergic system of the mouse brain. Eur J Neurosci 2014;39:218-28. [PMID: 24438489 DOI: 10.1111/ejn.12397] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
27 Tsujino N, Sakurai T. Role of orexin in modulating arousal, feeding, and motivation. Front Behav Neurosci 2013;7:28. [PMID: 23616752 DOI: 10.3389/fnbeh.2013.00028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 136] [Article Influence: 15.0] [Reference Citation Analysis]
28 Naganuma F, Nakamura T, Yoshikawa T, Iida T, Miura Y, Kárpáti A, Matsuzawa T, Yanai A, Mogi A, Mochizuki T, Okamura N, Yanai K. Histamine N-methyltransferase regulates aggression and the sleep-wake cycle. Sci Rep 2017;7:15899. [PMID: 29162912 DOI: 10.1038/s41598-017-16019-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
29 Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019;20:83-93. [PMID: 30546103 DOI: 10.1038/s41583-018-0097-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
30 Etori K, Saito YC, Tsujino N, Sakurai T. Effects of a newly developed potent orexin-2 receptor-selective antagonist, compound 1 m, on sleep/wakefulness states in mice. Front Neurosci 2014;8:8. [PMID: 24550770 DOI: 10.3389/fnins.2014.00008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
31 Liu M, Blanco-Centurion C, Shiromani PJ. Rewiring brain circuits to block cataplexy in murine models of narcolepsy. Curr Opin Neurobiol 2017;44:110-5. [PMID: 28445807 DOI: 10.1016/j.conb.2017.03.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Wu Y, Wang L, Yang F, Xi W. Neural Circuits for Sleep-Wake Regulation. Adv Exp Med Biol 2020;1284:91-112. [PMID: 32852742 DOI: 10.1007/978-981-15-7086-5_8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Giblin KA, Basili D, Afzal AM, Rosenbrier-Ribeiro L, Greene N, Barrett I, Hughes SJ, Bender A. New Associations between Drug-Induced Adverse Events in Animal Models and Humans Reveal Novel Candidate Safety Targets. Chem Res Toxicol 2021;34:438-51. [PMID: 33338378 DOI: 10.1021/acs.chemrestox.0c00311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 De la Herrán-arita AK, Drucker-colín R. Models for narcolepsy with cataplexy drug discovery. Expert Opinion on Drug Discovery 2012;7:155-64. [DOI: 10.1517/17460441.2012.651454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Kornum BR, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol 2011;21:897-903. [PMID: 21963829 DOI: 10.1016/j.conb.2011.09.003] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 8.0] [Reference Citation Analysis]
36 de Lecea L. Optogenetic control of hypocretin (orexin) neurons and arousal circuits. Curr Top Behav Neurosci 2015;25:367-78. [PMID: 25502546 DOI: 10.1007/7854_2014_364] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
37 Zhu L, Chamberlin NL, Arrigoni E. Muscarinic Inhibition of Hypoglossal Motoneurons: Possible Implications for Upper Airway Muscle Hypotonia during REM Sleep. J Neurosci 2019;39:7910-9. [PMID: 31420456 DOI: 10.1523/JNEUROSCI.0461-19.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 McShane BB, Jensen ST, Pack AI, Wyner AJ. Statistical Learning with Time Series Dependence: An Application to Scoring Sleep in Mice. J Am Stat Assoc 2013;108:1147-62. [PMID: 24504359 DOI: 10.1080/01621459.2013.779838] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
39 Bocian R, Kazmierska P, Kłos-Wojtczak P, Kowalczyk T, Konopacki J. Orexinergic theta rhythm in the rat hippocampal formation: In vitro and in vivo findings. Hippocampus 2015;25:1393-406. [PMID: 25820995 DOI: 10.1002/hipo.22459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
40 Kovac S, Wright MA, Eriksson SH, Zrinzo L, Matharu M, Walker MC. The effect of posterior hypothalamus region deep brain stimulation on sleep. Cephalalgia 2014;34:219-23. [PMID: 24045569 DOI: 10.1177/0333102413505241] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
41 Peever J, Fuller PM. The Biology of REM Sleep. Current Biology 2017;27:R1237-48. [DOI: 10.1016/j.cub.2017.10.026] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 20.6] [Reference Citation Analysis]
42 Stilling RM, Rönicke R, Benito E, Urbanke H, Capece V, Burkhardt S, Bahari-Javan S, Barth J, Sananbenesi F, Schütz AL, Dyczkowski J, Martinez-Hernandez A, Kerimoglu C, Dent SY, Bonn S, Reymann KG, Fischer A. K-Lysine acetyltransferase 2a regulates a hippocampal gene expression network linked to memory formation. EMBO J 2014;33:1912-27. [PMID: 25024434 DOI: 10.15252/embj.201487870] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
43 Ferrari LL, Park D, Zhu L, Palmer MR, Broadhurst RY, Arrigoni E. Regulation of Lateral Hypothalamic Orexin Activity by Local GABAergic Neurons. J Neurosci 2018;38:1588-99. [PMID: 29311142 DOI: 10.1523/JNEUROSCI.1925-17.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
44 Sakurai T. Orexin deficiency and narcolepsy. Curr Opin Neurobiol 2013;23:760-6. [PMID: 23663890 DOI: 10.1016/j.conb.2013.04.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
45 Fuller PM, Yamanaka A, Lazarus M. How genetically engineered systems are helping to define, and in some cases redefine, the neurobiological basis of sleep and wake. Temperature (Austin) 2015;2:406-17. [PMID: 27227054 DOI: 10.1080/23328940.2015.1075095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
46 Brown JA, Woodworth HL, Leinninger GM. To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance. Front Syst Neurosci 2015;9:9. [PMID: 25741247 DOI: 10.3389/fnsys.2015.00009] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
47 de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16. [PMID: 24575043 DOI: 10.3389/fphar.2014.00016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 8.5] [Reference Citation Analysis]
48 Scott MM, Marcus JN, Pettersen A, Birnbaum SG, Mochizuki T, Scammell TE, Nestler EJ, Elmquist JK, Lutter M. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav Brain Res 2011;222:289-94. [PMID: 21377495 DOI: 10.1016/j.bbr.2011.02.044] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 7.6] [Reference Citation Analysis]
49 Mieda M, Tsujino N, Sakurai T. Differential roles of orexin receptors in the regulation of sleep/wakefulness. Front Endocrinol (Lausanne) 2013;4:57. [PMID: 23730297 DOI: 10.3389/fendo.2013.00057] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
50 Sakurai T. The role of orexin in motivated behaviours. Nat Rev Neurosci 2014;15:719-31. [DOI: 10.1038/nrn3837] [Cited by in Crossref: 244] [Cited by in F6Publishing: 221] [Article Influence: 30.5] [Reference Citation Analysis]
51 Rolls A. Hypothalamic Control of Sleep in Aging. Neuromol Med 2012;14:139-53. [DOI: 10.1007/s12017-012-8175-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
52 Wang RF, Guo H, Jiang SY, Liu ZL, Qu WM, Huang ZL, Wang L. Control of wakefulness by lateral hypothalamic glutamatergic neurons in male mice. J Neurosci Res 2021;99:1689-703. [PMID: 33713502 DOI: 10.1002/jnr.24828] [Reference Citation Analysis]
53 Alexandre C, Andermann ML, Scammell TE. Control of arousal by the orexin neurons. Curr Opin Neurobiol 2013;23:752-9. [PMID: 23683477 DOI: 10.1016/j.conb.2013.04.008] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 8.0] [Reference Citation Analysis]
54 Mieda M, Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status. CNS Drugs 2013;27:83-90. [PMID: 23359095 DOI: 10.1007/s40263-012-0036-8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 6.9] [Reference Citation Analysis]
55 Tran D, Bonaventure P, Hack M, Mirzadegan T, Dvorak C, Letavic M, Carruthers N, Lovenberg T, Sutton SW. Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists. European Journal of Pharmacology 2011;667:120-8. [DOI: 10.1016/j.ejphar.2011.05.074] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
56 Schöne C, Burdakov D. Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain. Curr Top Behav Neurosci 2017;33:51-74. [PMID: 27830577 DOI: 10.1007/7854_2016_45] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
57 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Irukayama-Tomobe Y, Ogawa Y, Tominaga H, Ishikawa Y, Hosokawa N, Ambai S, Kawabe Y, Uchida S, Nakajima R, Saitoh T, Kanda T, Vogt K, Sakurai T, Nagase H, Yanagisawa M. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models. Proc Natl Acad Sci U S A 2017;114:5731-6. [PMID: 28507129 DOI: 10.1073/pnas.1700499114] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 10.6] [Reference Citation Analysis]
59 Li SB, de Lecea L. The hypocretin (orexin) system: from a neural circuitry perspective. Neuropharmacology 2020;167:107993. [PMID: 32135427 DOI: 10.1016/j.neuropharm.2020.107993] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
60 Li SB, Giardino WJ, de Lecea L. Hypocretins and Arousal. Curr Top Behav Neurosci 2017;33:93-104. [PMID: 28012091 DOI: 10.1007/7854_2016_58] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
61 Williams RH, Chee MJ, Kroeger D, Ferrari LL, Maratos-Flier E, Scammell TE, Arrigoni E. Optogenetic-mediated release of histamine reveals distal and autoregulatory mechanisms for controlling arousal. J Neurosci 2014;34:6023-9. [PMID: 24760861 DOI: 10.1523/JNEUROSCI.4838-13.2014] [Cited by in Crossref: 59] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
62 Blanco-Centurion C, Liu M, Konadhode R, Pelluru D, Shiromani PJ. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice. Sleep 2013;36:31-40. [PMID: 23288969 DOI: 10.5665/sleep.2296] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
63 Kukkonen JP. Physiology of the orexinergic/hypocretinergic system: a revisit in 2012. Am J Physiol Cell Physiol 2013;304:C2-32. [PMID: 23034387 DOI: 10.1152/ajpcell.00227.2012] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 9.3] [Reference Citation Analysis]
64 Wu F, Song Y, Li F, He X, Ma J, Feng T, Guan B, Wang L, Li S, Liu X, Liu Y, Mao M, Liu J, Bai S, Song C. Wen-dan decoction improves negative emotions in sleep-deprived rats by regulating orexin-a and leptin expression. Evid Based Complement Alternat Med 2014;2014:872547. [PMID: 24864160 DOI: 10.1155/2014/872547] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
65 Idris I, Abdulla H, Tilbrook S, Dean R, Ali N. Exenatide improves excessive daytime sleepiness and wakefulness in obese patients with type 2 diabetes without obstructive sleep apnoea. J Sleep Res 2013;22:70-5. [PMID: 22716195 DOI: 10.1111/j.1365-2869.2012.01030.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
66 Singh C, Oikonomou G, Prober DA. Norepinephrine is required to promote wakefulness and for hypocretin-induced arousal in zebrafish. Elife 2015;4:e07000. [PMID: 26374985 DOI: 10.7554/eLife.07000] [Cited by in Crossref: 61] [Cited by in F6Publishing: 40] [Article Influence: 8.7] [Reference Citation Analysis]
67 Arrigoni E, Chen MC, Fuller PM. The anatomical, cellular and synaptic basis of motor atonia during rapid eye movement sleep. J Physiol 2016;594:5391-414. [PMID: 27060683 DOI: 10.1113/JP271324] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
68 Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med 2020;68:97-109. [PMID: 32032921 DOI: 10.1016/j.sleep.2019.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
69 Parmentier R, Zhao Y, Perier M, Akaoka H, Lintunen M, Hou Y, Panula P, Watanabe T, Franco P, Lin JS. Role of histamine H1-receptor on behavioral states and wake maintenance during deficiency of a brain activating system: A study using a knockout mouse model. Neuropharmacology 2016;106:20-34. [PMID: 26723880 DOI: 10.1016/j.neuropharm.2015.12.014] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
70 Riday TT, Fish EW, Robinson JE, Jarrett TM, McGuigan MM, Malanga CJ. Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice. Brain Res 2012;1431:53-61. [PMID: 22133306 DOI: 10.1016/j.brainres.2011.11.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
71 Geerling JC. Waking under pressure. Sleep Medicine 2013;14:1045-6. [DOI: 10.1016/j.sleep.2013.08.779] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Mang GM, Dürst T, Bürki H, Imobersteg S, Abramowski D, Schuepbach E, Hoyer D, Fendt M, Gee CE. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors. Sleep 2012;35:1625-35. [PMID: 23204605 DOI: 10.5665/sleep.2232] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
73 Valko PO, Gavrilov YV, Yamamoto M, Reddy H, Haybaeck J, Mignot E, Baumann CR, Scammell TE. Increase of histaminergic tuberomammillary neurons in narcolepsy: Histaminergic Neurons. Ann Neurol 2013;74:794-804. [DOI: 10.1002/ana.24019] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 10.6] [Reference Citation Analysis]
74 Carter ME, de Lecea L, Adamantidis A. Functional wiring of hypocretin and LC-NE neurons: implications for arousal. Front Behav Neurosci 2013;7:43. [PMID: 23730276 DOI: 10.3389/fnbeh.2013.00043] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.7] [Reference Citation Analysis]
75 Mieda M. The roles of orexins in sleep/wake regulation. Neuroscience Research 2017;118:56-65. [DOI: 10.1016/j.neures.2017.03.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 8.4] [Reference Citation Analysis]
76 Mignot E. Narcolepsy. Principles and Practice of Sleep Medicine. Elsevier; 2017. pp. 855-872.e7. [DOI: 10.1016/b978-0-323-24288-2.00089-1] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
77 Nepovimova E, Janockova J, Misik J, Kubik S, Stuchlik A, Vales K, Korabecny J, Mezeiova E, Dolezal R, Soukup O, Kobrlova T, Pham NL, Nguyen TD, Konecny J, Kuca K. Orexin supplementation in narcolepsy treatment: A review. Med Res Rev 2019;39:961-75. [PMID: 30426515 DOI: 10.1002/med.21550] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
78 Kosse C, Burdakov D. A unifying computational framework for stability and flexibility of arousal. Front Syst Neurosci 2014;8:192. [PMID: 25368557 DOI: 10.3389/fnsys.2014.00192] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
79 Kantor S, Mochizuki T, Lops SN, Ko B, Clain E, Clark E, Yamamoto M, Scammell TE. Orexin gene therapy restores the timing and maintenance of wakefulness in narcoleptic mice. Sleep 2013;36:1129-38. [PMID: 23904672 DOI: 10.5665/sleep.2870] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
80 Antelmi E, Ferri R, Iranzo A, Arnulf I, Dauvilliers Y, Bhatia KP, Liguori R, Schenck CH, Plazzi G. From state dissociation to status dissociatus. Sleep Medicine Reviews 2016;28:5-17. [DOI: 10.1016/j.smrv.2015.07.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
81 Scammell TE, Arrigoni E, Lipton JO. Neural Circuitry of Wakefulness and Sleep. Neuron 2017;93:747-65. [PMID: 28231463 DOI: 10.1016/j.neuron.2017.01.014] [Cited by in Crossref: 298] [Cited by in F6Publishing: 257] [Article Influence: 59.6] [Reference Citation Analysis]
82 Sun Y, Jiang SY, Ni J, Luo YJ, Chen CR, Hong ZY, Yanagawa Y, Qu WM, Wang L, Huang ZL. Ethanol inhibits histaminergic neurons in mouse tuberomammillary nucleus slices via potentiating GABAergic transmission onto the neurons at both pre- and postsynaptic sites. Acta Pharmacol Sin 2016;37:1325-36. [PMID: 27498778 DOI: 10.1038/aps.2016.66] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
83 Ni LY, Zhu MJ, Song Y, Liu XM, Tang JY. Pentylenetetrazol-induced seizures are exacerbated by sleep deprivation through orexin receptor-mediated hippocampal cell proliferation. Neurol Sci 2014;35:245-52. [DOI: 10.1007/s10072-013-1495-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
84 Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW. Control of sleep and wakefulness. Physiol Rev 2012;92:1087-187. [PMID: 22811426 DOI: 10.1152/physrev.00032.2011] [Cited by in Crossref: 700] [Cited by in F6Publishing: 590] [Article Influence: 70.0] [Reference Citation Analysis]
85 Hirschberg PR, Sarkar P, Teegala SB, Routh VH. Ventromedial hypothalamus glucose-inhibited neurones: A role in glucose and energy homeostasis? J Neuroendocrinol 2020;32:e12773. [PMID: 31329314 DOI: 10.1111/jne.12773] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
86 Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev 2012;64:389-420. [DOI: 10.1124/pr.111.005546] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 11.4] [Reference Citation Analysis]
87 Zecharia AY, Yu X, Götz T, Ye Z, Carr DR, Wulff P, Bettler B, Vyssotski AL, Brickley SG, Franks NP, Wisden W. GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness. J Neurosci 2012;32:13062-75. [PMID: 22993424 DOI: 10.1523/JNEUROSCI.2931-12.2012] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
88 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
89 Chen Q, de Lecea L, Hu Z, Gao D. The hypocretin/orexin system: an increasingly important role in neuropsychiatry. Med Res Rev 2015;35:152-97. [PMID: 25044006 DOI: 10.1002/med.21326] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 5.5] [Reference Citation Analysis]
90 Michael NJ, Elmquist JK. Coordination of metabolism, arousal, and reward by orexin/hypocretin neurons. J Clin Invest 2020;130:4540-2. [PMID: 32804153 DOI: 10.1172/JCI140585] [Reference Citation Analysis]
91 Kohlmeier KA, Tyler CJ, Kalogiannis M, Ishibashi M, Kristensen MP, Gumenchuk I, Chemelli RM, Kisanuki YY, Yanagisawa M, Leonard CS. Differential actions of orexin receptors in brainstem cholinergic and monoaminergic neurons revealed by receptor knockouts: implications for orexinergic signaling in arousal and narcolepsy. Front Neurosci 2013;7:246. [PMID: 24391530 DOI: 10.3389/fnins.2013.00246] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
92 Perez MV, Pavlovic A, Shang C, Wheeler MT, Miller CL, Liu J, Dewey FE, Pan S, Thanaporn PK, Absher D, Brandimarto J, Salisbury H, Chan K, Mukherjee R, Konadhode RP, Myers RM, Sedehi D, Scammell TE, Quertermous T, Cappola T, Ashley EA. Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure. J Am Coll Cardiol 2015;66:2522-33. [PMID: 26653627 DOI: 10.1016/j.jacc.2015.09.061] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
93 Leonard CS, Kukkonen JP. Orexin/hypocretin receptor signalling: a functional perspective. Br J Pharmacol 2014;171:294-313. [PMID: 23848055 DOI: 10.1111/bph.12296] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
94 Haas HL, Lin J. Waking with the hypothalamus. Pflugers Arch - Eur J Physiol 2012;463:31-42. [DOI: 10.1007/s00424-011-0996-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
95 Pintwala SK, Peever J. Brain Circuits Underlying Narcolepsy. Neuroscientist 2021;:10738584211052263. [PMID: 34704497 DOI: 10.1177/10738584211052263] [Reference Citation Analysis]